{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:57:53Z","timestamp":1785560273128,"version":"3.56.0"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7515-26","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:11:32Z","timestamp":1785535892000},"source":"Crossref","is-referenced-by-count":0,"title":["Multicenter Retrospective Study of LCIG Therapy in Japan: Efficacy, Factors Associated with Discontinuation, and Case-based Insights"],"prefix":"10.2169","author":[{"given":"Shinsuke","family":"Fujioka","sequence":"first","affiliation":[{"name":"Department of Neurology, Fukuoka University School of Medicine, Japan"},{"name":"Department of Neurology, Takagi Hospital, Japan"},{"name":"Department of Neurology, International University of Health and Welfare, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayasu","family":"Mishima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University School of Medicine, Japan"},{"name":"Division of Neurology, Department of Internal Medicine, Sakura Medical Center, Toho University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yasutaka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University School of Medicine, Japan"},{"name":"School of Pharmaceutical Sciences, Faculty of Pharmacy, International University of Health and Welfare, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotoe","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Watari","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical Co. LTA Fukuoka Mirai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Miyagi","sequence":"additional","affiliation":[{"name":"Department of Stereotactic and Functional Neurosurgery, Medical Co. LTA Fukuoka Mirai Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hashiguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fujimoto General Hospital, Japan"},{"name":"Betesuda Clinic, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tokashiki","sequence":"additional","affiliation":[{"name":"Division of Neurology, National Okinawa Hospital, National Hospital Organization, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Tsuruta","sequence":"additional","affiliation":[{"name":"Department of Neurology, Junwakai Memorial Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Kurisaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Kumamoto Saishun Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Matsuse","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Uozumi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kitakyushu General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University School of Medicine, Japan"},{"name":"Department of Neurology, Graduate School of Medicine, Juntendo University, Japan"},{"name":"Parkinson&apos;s Disease Specialty Clinic, Tsutsumi Clinic, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Marsili L, Bologna M, Chen LY, et al. Treatment of motor symptoms of Parkinson&apos;s disease. Neurol Clin 43: 341-363, 2025.","DOI":"10.1016\/j.ncl.2024.12.010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Chaudhuri KR, Antonini A, Pahwa R, et al. Effects of levodopa-carbidopa intestinal gel on dyskinesia and non-motor symptoms including sleep: Results from a meta-analysis with 24-month follow-up. J Parkinsons Dis 12: 2071-2083, 2022.","DOI":"10.3233\/JPD-223295"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kovacs N, Bergmann L, Anca-Herschkovitsch M, et al. Outcomes impacting quality of life in advanced Parkinson&apos;s disease patients treated with levodopa-carbidopa intestinal gel. J Parkinsons Dis 12: 917-926, 2022.","DOI":"10.3233\/JPD-212979"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fernandez HH, Vanagunas A, Odin P, et al. Levodopa-carbidopa intestinal gel in advanced Parkinson&apos;s disease open-label study: interim results. Parkinsonism Relat Disord 19: 339-345, 2013.","DOI":"10.1016\/j.parkreldis.2012.11.020"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Murata M, Mihara M, Hasegawa K, et al. Efficacy and safety of levodopa-carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson&apos;s disease patients. NPJ Parkinsons Dis 2: 16020, 2016.","DOI":"10.1038\/npjparkd.2016.20"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chaudhuri KR, Kovacs N, Pontieri FE, et al. Levodopa carbidopa intestinal gel in advanced Parkinson&apos;s disease: DUOGLOBE final 3-year results. J Parkinsons Dis 13: 769-783, 2023.","DOI":"10.3233\/JPD-225105"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Antonini A, Odin P, Pahwa R, et al. The long-term impact of levodopa\/carbidopa intestinal gel on &apos;off&apos;-time in patients with advanced Parkinson&apos;s disease: A systematic review. Adv Ther 38: 2854-2890, 2021.","DOI":"10.1007\/s12325-021-01747-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Magliozzi A, Feugas N, Poon YY, et al. Levodopa-carbidopa intestinal gel in an outpatient setting: A 10-year experience. Mov Disord Clin Pract 12: 1208, 2025.","DOI":"10.1002\/mdc3.70093"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Garri F, Russo FP, Carrer T, et al. Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson&apos;s disease on levodopa\/carbidopa intestinal gel infusion. J Neurol 269: 5606-5614, 2022.","DOI":"10.1007\/s00415-022-11269-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Constantin VA, Szasz JA, Orban-Kis K, et al. Levodopa-carbidopa intestinal gel infusion therapy discontinuation: A ten-year retrospective analysis of 204 treated patients. Neuropsychiatr Dis Treat 16: 1835-1844, 2020.","DOI":"10.2147\/NDT.S256988"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cyrany J, Rejchrt S, Kopacova M, et al. Buried bumper syndrome: A complication of percutaneous endoscopic gastrostomy. World J Gastroenterol 22: 618-627, 2016.","DOI":"10.3748\/wjg.v22.i2.618"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Spanaki C, Boura I, Avgoustaki A, et al. Buried bumper syndrome: A common complication of levodopa intestinal infusion for Parkinson disease. Parkinsonism Relat Disord 85: 59-62, 2021.","DOI":"10.1016\/j.parkreldis.2021.02.032"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kumar N, Murgai A, Naranian T, et al. Levodopa-carbidopa intestinal gel therapy after deep brain stimulation. Mov Disord 33: 334-335, 2018.","DOI":"10.1002\/mds.27211"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Elkouzi A, Ramirez-Zamora A, Zeilman P, et al. Rescue levodopa-carbidopa intestinal gel (LCIG) therapy in Parkinson&apos;s disease patients with suboptimal response to deep brain stimulation. Ann Clin Transl Neurol 6: 1989-1995, 2019.","DOI":"10.1002\/acn3.50889"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bautista JMP, Oyama G, Nuermaimaiti M, et al. Rescue levodopa\/carbidopa intestinal gel for secondary deep brain stimulation failure. J Mov Disord 13: 57-61, 2020.","DOI":"10.14802\/jmd.19051"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Boura I, Haliasos N, Giannopoulou Iota A, et al. Combining device-aided therapies in Parkinson&apos;s disease: A case series and a literature review. Mov Disord Clin Pract 8: 750-757, 2021.","DOI":"10.1002\/mdc3.13228"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Georgiev D, Delalic S, Zupancic Kriznar N, et al. Switching and combining device-aided therapies in advanced Parkinson&apos;s disease: A double centre retrospective study. Brain Sci 12: 343, 2022.","DOI":"10.3390\/brainsci12030343"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kimber TE, Zhuang Y, Thompson PD. Benefits of levodopa-carbidopa intestinal gel infusion in patients with Parkinson&apos;s disease experiencing gait dysfunction following subthalamic deep brain stimulation. J Mov Disord 12: 192-194, 2019.","DOI":"10.14802\/jmd.19022"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Noui Y, Silverdale MA, Evans J, et al. Parkinson&apos;s kinetigraph in the selection of levodopa-carbidopa intestinal gel for motor fluctuations refractory to deep brain stimulation. J Mov Disord 14: 239-241, 2021.","DOI":"10.14802\/jmd.20090"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7515-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:13:36Z","timestamp":1785557616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7515-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":19,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7515-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7515-26"}}